Healthcare Services Acquisitions in New Jersey

Healthcare Services Deals in New Jersey

Healthcare services acquisitions in New Jersey span multiple care settings and supporting healthcare infrastructure—from outpatient imaging and rehabilitation to behavioral health and clinical research. Across recent deals, buyers often look to add specialized clinical capabilities, expand geographic coverage within the state, and strengthen service lines that support payer, provider, or life sciences workflows.

Deal activity also shows an overlap between healthcare delivery and healthcare technology. Acquirers including Clinigen, ACL Digital, and Kodiak Solutions pursue add-on capabilities in areas like pharmaceutical services, CRO and pharmacovigilance, and reimbursement or revenue recovery—while operators such as Princeton Radiology and BriteLife Recovery focus on integrating new sites or outpatient programs into their existing care continuum.

Whether the transaction is a platform buildout or a targeted capability expansion, the common thread is strategic fit: expanding access to care (including complex trials and neuropsychiatric studies), extending regional footprints, or enhancing network, reimbursement, and advisory services serving healthcare stakeholders in New Jersey.

What Stands Out

  • New Jersey-based integration themes recur: outpatient imaging centers (e.g., Hamilton and Lawrenceville) and outpatient behavioral health programs (e.g., IOP services).
  • Life sciences and enabling tech are frequently targeted, including CRO services (clinical data management, biostatistics, writing, pharmacovigilance) and reimbursement/revenue recovery software.
  • Managed care and network capabilities appear in casualty-adjacent healthcare delivery via PPO network expansion.
  • Buyer types range from healthcare operators (e.g., radiology and physical therapy platforms) to services and technology providers backed by equity.
Buyer (examples) Deal theme reflected in NJ Example target category
Clinigen Expand global pharma services Strategic advisory / consulting
ACL Digital Add CRO + pharmacovigilance Clinical research outsourcing
Princeton Radiology Grow regional imaging footprint Outpatient imaging centers
WellLink Group Purchasing Broaden GPO reach Regional group purchasing organization
  • Buyer
    Icelandirect
    Target
    SOMA LABS
    Type
    Addon

    Icelandirect, a U.S.-based contract manufacturer and New Heritage Capital portfolio company, acquired SOMA LABS, a New Jersey supplement manufacturer specializing in solid dosage form production. The transaction closed in February 2026 and expands Icelandirect’s capabilities into additional dosage forms, enabling broader end-to-end manufacturing for both human nutrition and pet supplement brands.

  • Buyer
    Health Recovery Solutions (HRS)
    Target
    Rimidi
    Type
    Buyout

    Health Recovery Solutions (HRS) announced it has acquired Rimidi, a digital health company focused on chronic disease management and remote monitoring, particularly for diabetes and cardiometabolic care. The deal is intended to strengthen HRS’s enterprise remote patient care platform by combining HRS’s remote patient monitoring infrastructure with Rimidi’s EHR-integrated clinical decision support and CGM data workflow capabilities.

  • Buyer
    The HWP Group
    Target
    Global Market Access Solutions (GMAS)
    Type
    Buyout

    The HWP Group, a medical communications and strategic consulting partner to the life sciences industry, announced it has acquired Global Market Access Solutions (GMAS), a market access and health economics consultancy with global operations. The deal expands HWP’s capabilities across market access strategy, HEOR, pricing and payer insights, and lifecycle value strategy to support clients from early clinical development through reimbursement and sustained patient access.

  • Buyer
    MedRisk
    Target
    Horizon Casualty Services PPO Network business
    Seller
    Horizon Mutual Holdings

    MedRisk has acquired the Horizon Casualty Services (HCS) PPO Network business from Horizon Mutual Holdings. The deal expands MedRisk’s managed-care and network capabilities across the casualty claims market, enabling improved patient outcomes and greater value for clients in workers' compensation and auto casualty claims.

  • Buyer
    Kodiak Solutions, TPG
    Target
    Besler & Company (BESLER)
    Seller
    Besler & Company (BESLER)
    Type
    Addon

    Kodiak Solutions, a TPG-backed healthcare technology and services company based in Indianapolis, acquired Besler & Company (BESLER), a Princeton, New Jersey-based provider of revenue recovery and hospital reimbursement solutions, on January 22, 2026. The deal integrates BESLER's reimbursement software and managed-service capabilities into Kodiak's platform; Jonathan Besler joins Kodiak as a vice president and founder Philip Besler will retire.

  • Buyer
    PhaseWell Research
    Target
    Bio Behavioral Health
    Type
    Addon

    PhaseWell Research, a national clinical research site company, announced that Bio Behavioral Health has joined its network to expand access to neuropsychiatric and CNS clinical trials. The deal strengthens PhaseWell's community-based research capabilities and broadens patient access to complex clinical studies across its growing national footprint.

  • Buyer
    Princeton Radiology
    Target
    Radiology Affiliates Imaging (RAI) - Hamilton imaging center, Radiology Affiliates Imaging (RAI) - Lawrenceville imaging center
    Seller
    Radiology Affiliates Imaging (RAI), Radiology Partners
    Type
    Buyout

    Princeton Radiology has acquired two outpatient imaging centers in Hamilton and Lawrenceville, New Jersey from Radiology Affiliates Imaging (RAI), a Radiology Partners practice. The acquisition expands Princeton Radiology's regional footprint and will add new imaging capabilities (including whole-body MRI and enhanced breast screening) as the centers are integrated into its network.

  • Buyer
    SAI MedPartners
    Target
    The Dunn Group
    Type
    Addon

    SAI MedPartners, a Northlane Capital Partners-backed healthcare consultancy, has acquired The Dunn Group, a Totowa, New Jersey-based competitive intelligence firm focused on pharmaceuticals, biotechnology, and medical devices. The acquisition expands SAI's competitive intelligence capabilities and deepens its life sciences market research and analytics offerings.

  • Buyer
    BriteLife Recovery
    Target
    Summit Behavioral Health
    Type
    Buyout

    BriteLife Recovery has acquired Summit Behavioral Health, an established intensive outpatient program (IOP) in Princeton Junction, New Jersey, marking BriteLife’s first expansion into outpatient services. The acquisition integrates Summit’s IOP into BriteLife’s continuum of care and gives Summit access to BriteLife’s clinical, operational, and alumni resources.

  • November 21, 2025
    Buyer
    Clinigen
    Target
    SSI Strategy
    Type
    Buyout

    Clinigen has completed the acquisition of SSI Strategy, adding SSI's strategic advisory capabilities and an established U.S. and European footprint to Clinigen's global pharmaceutical services platform. The deal brings over 200 employees (including ~145 consultants) and a deep biotech client base to Clinigen, expanding its end-to-end lifecycle services from clinical strategy through global commercialisation.

  • Buyer
    LTS Lohmann Therapie-Systeme AG
    Target
    Renaissance Lakewood, LLC
    Seller
    RoundTable Healthcare Partners
    Type
    Buyout

    LTS Lohmann Therapie-Systeme AG (LTS) announced it will acquire Renaissance Lakewood, LLC, a U.S. contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms. The deal will expand LTS’s CDMO capabilities and integrate Renaissance’s facilities and workforce into LTS’s global operations network, subject to regulatory approvals and expected to close before the end of November 2025.

  • Buyer
    SportsMed Physical Therapy, Hildred Capital Management
    Target
    WeCare Medical PT and Wellness
    Type
    Addon

    SportsMed Physical Therapy, a Hildred Capital-backed outpatient rehabilitation platform, has acquired WeCare Medical PT and Wellness in Maplewood, New Jersey. The deal expands SportsMed's footprint to 51 clinics across New Jersey and Connecticut and adds services including physical therapy, occupational/hand therapy, chiropractic care, acupuncture and HomeCare.

  • September 26, 2025
    Buyer
    ACL Digital
    Target
    Symbiance
    Type
    Buyout

    ACL Digital, an ALTEN Group company, has acquired Symbiance, a US-based contract research organization (CRO) that provides clinical data management, biostatistics, medical writing and pharmacovigilance services. The acquisition expands ACL Digital's life sciences capabilities by adding AI-driven clinical research, CRO and pharmacovigilance expertise to its digital transformation and engineering services.

  • Buyer
    PAX Health, HCAP Partners, Hamilton Lane
    Target
    Neuropsychology and Counseling Associates
    Type
    Addon

    PAX Health, a behavioral health platform backed by HCAP Partners and funds managed by Hamilton Lane, has acquired Neuropsychology and Counseling Associates, a New Jersey-based outpatient mental health practice. The add-on expands PAX Health's neuropsychological and memory-support services and strengthens its geographic footprint across New Jersey while preserving the practice's specialized clinical offerings.

  • Buyer
    WellLink Group Purchasing
    Target
    Fairway GPO
    Type
    Buyout

    WellLink Group Purchasing (formerly CHAMPS GPO) has acquired Fairway GPO, a regional group purchasing organization based in New Jersey, to expand WellLink's national reach and enhance supplier and member benefits. The acquisition will combine Fairway's regional relationships with WellLink's national scale to deliver broader contract portfolios, greater savings opportunities, and continuity of service for members and suppliers.

  • Buyer
    Station Partners
    Target
    First Children Services

    Morristown, NJ-based private investment firm Station Partners made a strategic growth investment in First Children Services (FCS), a family-owned provider of center-, home- and school-based behavioral health and special education services. The capital will support FCS’s continued expansion across New Jersey and Pennsylvania and help broaden access to its therapeutic and special education offerings.

  • Buyer
    SportsMed Physical Therapy, Hildred Capital Management
    Target
    Ridgewood clinic (Ridgewood, NJ)
    Type
    Addon

    SportsMed Physical Therapy has acquired a new clinic in Ridgewood, New Jersey, bringing the platform to 49 locations across New Jersey and Connecticut. SportsMed, a portfolio company of Hildred Capital Management, continues its roll-up strategy to expand access to outpatient rehabilitation and wellness services in the region.

  • July 8, 2025
    Buyer
    Medvantx
    Target
    RxS
    Type
    Buyout

    Medvantx, a San Diego-based pharmacy services provider, has acquired RxS, a multichannel sample management and accountability solutions company headquartered in Manalapan, New Jersey. The acquisition integrates RxS’s sampling and engagement technology with Medvantx’s patient access, PAP fulfillment, telehealth and distribution services to broaden capability and accelerate access for pharmaceutical and device manufacturers.

  • Buyer
    Harvest Partners, LP, A&M Capital
    Target
    Med-Metrix, LLC

    Med-Metrix, a technology-enabled revenue cycle management (RCM) solutions provider, announced that funds managed by Harvest Partners will make a growth investment in the company. The deal is alongside management and existing investor A&M Capital, with management continuing to lead the business and retain significant ownership; financial terms were not disclosed.

  • Buyer
    Fujirebio Diagnostics, Inc., Fujirebio Holdings, Inc., H.U. Group Holdings Inc.
    Target
    Plasma Services Group, Inc.
    Type
    Buyout

    Fujirebio Diagnostics, a subsidiary of Fujirebio Holdings (H.U. Group), has acquired all shares of Plasma Services Group, a Moorestown, New Jersey-based supplier of rare biological samples and collection services for the IVD and life sciences industries. The acquisition strengthens Fujirebio's capability to supply high-quality and hard-to-obtain biological raw materials for diagnostics R&D and manufacturing; transaction value was not disclosed.

  • Buyer
    Surgical Information Systems (SIS)
    Target
    ASC Logs
    Type
    Buyout

    Surgical Information Systems (SIS) has acquired ASC Logs, a cloud-based compliance management platform for ambulatory surgery centers (ASCs). The deal adds electronic credentialing, digital logbooks, LMS and enterprise compliance tools to SIS's ASC software suite to streamline regulatory and operational compliance for surgery centers.

  • Buyer
    SportsMed Physical Therapy
    Target
    Mendham Physical Therapy
    Type
    Addon

    SportsMed Physical Therapy acquired Mendham Physical Therapy in Mendham, New Jersey, adding the clinic as the chain's 45th location. The acquisition is an add-on to SportsMed (a Hildred Capital Management portfolio company) to expand its outpatient rehabilitation footprint in Morris County and continue offering patient-centered physical therapy and related services.

  • Buyer
    NeoGenomics, Inc.
    Target
    Pathline, LLC
    Type
    Buyout

    NeoGenomics, Inc. (NASDAQ: NEO) has completed its acquisition of Pathline, LLC, a CLIA/CAP/NYS-certified pathology laboratory headquartered in Ramsey, New Jersey. The deal strengthens NeoGenomics' commercial presence in the Northeast United States and expands its molecular and hematology-oncology testing capabilities and access to its oncology test menu.

  • Buyer
    Johnson & Johnson
    Target
    Intra-Cellular Therapies, Inc.
    Type
    Buyout

    Johnson & Johnson has acquired Intra-Cellular Therapies, paying $132 per share in cash for all outstanding shares, for an equity value of approximately $14.6 billion. The deal adds CAPLYTA (lumateperone) and a clinical-stage pipeline, including ITI-1284, to strengthen J&J’s neuroscience portfolio.

  • Buyer
    Clearview Capital
    Target
    Advantage Behavioral Health
    Seller
    Founders (AJ Solomon and Brent Reese), Management team (including CEO Colin Studwell)

    Clearview Capital has recapitalized Advantage Behavioral Health in a transaction that closed April 1, partnering with the company's founders and management to provide growth capital and an experienced operational partner. Advantage Behavioral Health is an outpatient behavioral health network operating 21 locations in nine states and delivering roughly 500,000 patient visits annually via in-person and telehealth channels. Terms were not disclosed.

  • Buyer
    InTandem Capital Partners
    Target
    Clinilabs

    InTandem Capital Partners has made a strategic growth investment in Clinilabs, a global full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug and device development. The partnership with Clinilabs’ founder and management will support scaling the company’s neuroscience trial capabilities across Phase 1–3 and accelerate commercial and operational growth.

  • Buyer
    Smartlinx
    Target
    Bektek
    Type
    Buyout

    Smartlinx has acquired Bektek, a provider of timekeeping, scheduling and payroll HR software for healthcare, to expand its workforce management and human capital offerings for senior care. Bektek will remain led by CEO Zev Beckerman and headquartered in Hackensack, New Jersey; the deal builds on Lone View Capital's 2023 strategic investment in Smartlinx.

  • Buyer
    Frazier Healthcare Partners
    Target
    Knipper Health
    Seller
    Court Square Capital Partners
    Type
    Buyout

    Frazier Healthcare Partners has acquired Knipper Health from Court Square Capital Partners in a transaction that closed in February 2025. Knipper Health, headquartered in Lakewood, New Jersey, provides sample management & marketing, custom pharmacy solutions and third-party logistics to pharmaceutical, biotechnology and medical device companies; financial terms were not disclosed.

  • Buyer
    Undisclosed strategic buyer
    Target
    MedForce
    Seller
    Eureka Equity Partners

    Eureka Equity Partners has sold MedForce, a Shrewsbury, New Jersey-based medical communications firm that provides scientific content development and healthcare professional engagement services, to an undisclosed strategic buyer. MedForce, which leverages its proprietary aiovance platform and deep expertise in oncology, rare disease and specialty drugs, was supported in the transaction by Piper Sandler & Co. (financial advisor) and Morgan, Lewis & Bockius LLP (legal advisor).

  • Buyer
    Abound Health Inc.
    Target
    Star Pediatric Home Care Agency
    Seller
    Star Pediatric shareholders
    Type
    Addon

    Abound Health has entered a strategic partnership with Star Pediatric Home Care Agency, a leading private-duty nursing provider for medically complex pediatric patients based in Saddle Brook, New Jersey. The deal will expand Abound's service footprint and capabilities across New Jersey, Pennsylvania and North Carolina and is being executed as an add-on to Abound's multi-state platform.

  • Buyer
    Clearway Pain Solutions
    Target
    Eastern Neurodiagnostic Associates P.C.
    Seller
    Dr. Shiva Gopal Vasishta (founder)
    Type
    Buyout

    Clearway Pain Solutions has acquired Eastern Neurodiagnostic Associates P.C., a multi-specialty neurology and pain management practice serving Southern New Jersey. The practice will continue operating under its existing brand while joining Clearway's Southern New Jersey footprint to expand patient access to neurology, pain management, and neuropsychology services.

  • Buyer
    Lantheus Holdings, Inc.
    Target
    Evergreen Theragnostics, Inc.
    Type
    Buyout

    Lantheus Holdings has signed a definitive agreement to acquire Evergreen Theragnostics in an all-cash deal with a $250 million upfront payment and up to $752.5 million in development and sales milestones. The acquisition is intended to expand Lantheus into a fully integrated radiopharmaceutical leader by adding Evergreen’s radiopharmaceutical CDMO manufacturing infrastructure and development capabilities, as well as the registrational-stage PET diagnostic agent OCTEVY.

  • Buyer
    Integrated Foot and Ankle Specialists (IFAS), Mereo Capital Partners
    Target
    Comprehensive Foot & Ankle Center of South Jersey
    Type
    Addon

    Integrated Foot and Ankle Specialists (IFAS), a podiatry platform backed by Mereo Capital Partners, acquired Comprehensive Foot & Ankle Center of South Jersey (CFAC), a multi-location practice with offices in Voorhees, Cherry Hill, Atco and Turnersville. The deal expands the IFAS platform to 15 practices and 27 locations and increases its presence in New Jersey.

  • Buyer
    Funds managed by Harvest Partners Ascend Management, LP (Harvest Ascend)
    Target
    Alumni Staffing

    Funds managed by Harvest Partners Ascend Management, LP ("Harvest Ascend") have made a strategic growth investment in Alumni Staffing, a locum tenens staffing firm headquartered in Bridgewater, New Jersey. The capital will fund investments in talent development, technology, specialty expertise and geographic expansion; Alumni's founder and management team will remain significant shareholders and several Harvest Ascend partners will join the company's board.

  • Buyer
    Novo Holdings A/S, Novo Nordisk A/S
    Target
    Catalent, Inc.
    Type
    Buyout

    Novo Holdings A/S agreed to acquire Catalent, Inc. in an all-cash transaction valued at approximately $16.5 billion ($63.50 per share). The deal was later completed, and Catalent became a private company under Novo Holdings ownership; Novo Nordisk subsequently acquired Catalent’s three fill-finish sites in Italy, Indiana (USA), and Belgium.

  • Buyer
    Medical Technology Associates, LLC (MTA)
    Target
    Major Medical Hospital Services, Inc.
    Type
    Buyout

    Medical Technology Associates, LLC (MTA) has acquired Major Medical Hospital Services, Inc., a West Berlin, New Jersey–based provider of medical gas services, equipment distribution, and compliance testing. The acquisition expands MTA’s service and equipment footprint into Northeastern U.S. markets and brings Major Medical’s management and employees into MTA while maintaining current operations.

  • Buyer
    MJH Life Sciences
    Target
    Revolutionizing Atopic Dermatitis (RAD) Annual Meeting
    Type
    Buyout

    MJH Life Sciences has acquired the Revolutionizing Atopic Dermatitis (RAD) Annual Meeting, a CME-certified conference focused on advances in dermatology. The meeting will be integrated into MJH's multichannel education model and the legacy meetings portfolio of Physicians' Education Resource (PER), expanding MJH's dermatology education offerings with support from its established brands and PE backers.

  • Buyer
    1315 Capital
    Target
    SciSafe
    Seller
    BioLife Solutions, Inc.

    1315 Capital, a Philadelphia-based growth equity firm, has acquired SciSafe from BioLife Solutions in an all-cash transaction that establishes SciSafe as an independent, standalone biostorage company. The deal accompanies a growth capital investment to fund expansion of SciSafe's biostorage, cold-chain and compliance capabilities and to support global footprint growth.

  • Buyer
    Gridiron Capital, WestView Capital Partners (reinvesting), Health Monitor management (reinvesting)
    Target
    Health Monitor Network
    Seller
    WestView Capital Partners

    Gridiron Capital led a majority recapitalization of Health Monitor Network, with existing investor WestView Capital Partners receiving liquidity while remaining a material shareholder. Health Monitor CEO David Paragamian and the management team are reinvesting and will continue to lead the company as Gridiron supports accelerated growth across channels and new products; financial terms were not disclosed.

  • Buyer
    Organon
    Target
    Dermavant Sciences Ltd.
    Seller
    Roivant
    Type
    Buyout

    Organon entered into a definitive agreement to acquire Dermavant Sciences Ltd., including its immuno-dermatology product VTAMA (tapinarof) cream, 1%, for up to approximately $1.2 billion in aggregate consideration. Organon completed the acquisition in October 2024, expanding its dermatology capabilities in the U.S. with a nonbiologic, non-steroidal topical therapy for plaque psoriasis, and with atopic dermatitis under FDA review.

  • Buyer
    Panacea Healthcare Solutions, Firmament
    Target
    CBIZ KA Consulting Services, LLC (KA Consulting)
    Type
    Addon

    Firmament-backed Panacea Healthcare Solutions has acquired CBIZ KA Consulting Services, LLC (KA Consulting) to expand its eligibility determination, clinical coding & auditing, and revenue integrity capabilities for U.S. hospitals and health systems. The KA Consulting leadership team will be integrated into Panacea, with George Kelley named President of Panacea’s new KA Consulting division to support expanded revenue integrity and compliance offerings.

  • Buyer
    Danforth Advisors, LLC
    Target
    Advyzom, LLC
    Type
    Buyout

    Danforth Advisors has acquired Advyzom, a New Jersey–based regulatory affairs consultancy of approximately 30 specialists, expanding Danforth's clinical and regulatory capabilities to offer a comprehensive suite of services for life science companies. The acquisition integrates Advyzom's regulatory strategy, FDA liaison, medical writing, and submissions expertise into Danforth's platform to better support clients across development, approval, and market entry.

  • Buyer
    Emry Health, Goodroot
    Target
    Medical Cost Advocate (MCA)
    Type
    Addon

    Goodroot has merged Medical Cost Advocate (MCA) into its benefit navigation company, Emry Health, combining MCA's concierge advocacy and claims negotiation capabilities with Emry's employer-focused benefit navigation platform. The deal is an add-on integration intended to expand Emry's capabilities and extend its services to both concierge and corporate clients across the U.S.

  • Buyer
    Dynamic Infusion, RiverGlade Capital
    Target
    IV Solutions Group, LLC d/b/a Infusicare
    Seller
    James Reardon
    Type
    Addon

    Dynamic Infusion, a home infusion nursing services platform backed by RiverGlade Capital, has acquired IV Solutions Group, LLC d/b/a Infusicare, a New Jersey-based provider of home infusion nursing services founded by James Reardon. The acquisition expands Dynamic's footprint into central and northern New Jersey and brings Infusicare's nurses and clients into Dynamic's nationwide home-infusion network; Reardon will continue working with Dynamic in the region.

  • Buyer
    Tobin Scientific
    Target
    BioRepository Resources LLC
    Type
    Buyout

    Tobin Scientific, a provider of cold chain, ambient storage, and logistics services for the life sciences industry, has acquired BioRepository Resources LLC, a New Providence, New Jersey-based biorepository operator. The acquisition expands Tobin Scientific's biopharma storage and biorepository capabilities, adding over 2 million samples and enhancing its GxP-compliant long-term biological sample storage offerings.

  • Buyer
    Harvest Integrated Research Organization (HiRO)
    Target
    DeltaMed Solutions
    Type
    Buyout

    Harvest Integrated Research Organization (HiRO), a global clinical research organization, has acquired DeltaMed Solutions, a New Jersey–based contract research organization (CRO). The deal expands HiRO’s cross-border footprint and service capabilities in the US and strengthens its global clinical trial offering across data management, biostatistics, regulatory affairs and RWE solutions.

  • Buyer
    Calibre Scientific
    Target
    American Chromatography Supplies LLC
    Type
    Buyout

    Calibre Scientific has acquired American Chromatography Supplies LLC (ACS), a U.S. supplier of chromatography consumables, expanding Calibre's chromatography product portfolio and distribution capabilities. ACS, founded in 2011, supplies vials, caps, HPLC/GC columns and other lab consumables to pharmaceutical, academic, clinical, food & beverage, and environmental laboratories in the United States.

  • Buyer
    Inception Fertility
    Target
    Reproductive Science Center of New Jersey
    Seller
    Reproductive Science Center of New Jersey
    Type
    Buyout

    Inception Fertility has acquired Reproductive Science Center of New Jersey. Dresner Partners advised Reproductive Science Center of New Jersey on the undisclosed-sale, which expands Inception's growing network of fertility clinics and capabilities in assisted reproductive technologies.

  • Buyer
    Verista, Lightview Capital
    Target
    ILB Enterprises
    Type
    Addon

    Verista has acquired ILB Enterprises, a New Jersey–based life sciences consulting firm specializing in pharmacovigilance, safety compliance, program and project management. The deal, led by Verista's private equity sponsor Lightview Capital, expands Verista's capabilities across compliance, automation and validation and strengthens its Mid‑Atlantic life sciences services footprint.

  • Buyer
    JPA Health
    Target
    BioCentric, Inc.
    Type
    Buyout

    JPA Health, a global full-service integrated health agency, has acquired BioCentric, Inc., an award-winning medical communications agency known for scientific storytelling, clinical trial acceleration, and HCP engagement. BioCentric will become JPA Health’s medical communications and learning experiences arm, with founder Sherine Aly continuing to lead the division and offices in Collingswood, New Jersey and Lausanne, Switzerland.

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.

Frequently Asked Questions

What kinds of healthcare services are being acquired in New Jersey?

Recent NJ deals include outpatient imaging centers, outpatient behavioral health programs, physical therapy and wellness practices, revenue recovery and reimbursement solutions, clinical research/CRO capabilities, and group purchasing organizations (GPOs).

Do these acquisitions focus only on direct care providers?

No. The page also highlights supporting healthcare services and life sciences enablement—such as reimbursement software, competitive intelligence for biotech/pharma/medical devices, and CRO services including pharmacovigilance.

Which recurring buyers or buyer types appear across the transactions?

Recurring names include healthcare service operators and services-focused acquirers such as Professional Physical Therapy, Clinigen, ACL Digital, Princeton Radiology, and investment-backed platforms like Caymus Equity Partners LLC and TPG (appearing alongside specific deal entries).

Are the deals limited to one part of New Jersey?

No. The acquisitions reference multiple NJ locations across the state (for example, imaging centers in Hamilton and Lawrenceville; an IOP in Princeton Junction; and facilities/services in Maplewood and Totowa), reflecting a state-wide footprint-building approach.

Related Acquisition Pages